共 108 条
- [1] Egan TD(1993)The pharmacokinetics of the new short-acting opioid remifentanil (GI87084B) in healthy adult male volunteers Anesthesiology 79 881-892
- [2] Lemmens HJ(1993)Pharmacokinetics of remifentanil (G187084B) and its major metabolite (GR90291) in patients undergoing elective surgery Anesthesiology 79 893-903
- [3] Fiset P(1995)Measured context-sensitive half-times of remifentanil and alfentanil Anesthesiology 83 968-975
- [4] Hermann DJ(2004)Pharmacokinetics of remifentanil and its major metabolite, remifentanil acid, in ICU patients with renal impairment Br J Anaesth 92 493-503
- [5] Muir KT(2004)Offset of pharmacodynamic effects and safety of remifentanil in intensive care unit patients with various degrees of renal impairment Crit Care 8 R21-R30
- [6] Stanski DR(1996)Remifentanil in the critically ill: what will its place be? Br J Intensive Care 79 893-903
- [7] Shafer SL(1998)Remifentanil as an analgesic in the critically ill Anaesthesia 53 823-824
- [8] Westmorland CL(1999)The use of remifentanil in critically ill patients. Clinical findings and early experience Anaesthesist 48 625-629
- [9] Hoke JF(2000)Safety and feasibility of continuous infusion of remifentanil in the neurosurgical intensive care unit Neurosurgery 46 596-601
- [10] Sebel PS(2004)Remifentanil versus fentanyl for analgesia based sedation to provide patient comfort in the intensive care unit: a randomised control trial [ISRCTN43755713] Crit Care 8 R1-R11